Pure Bioscience Stock Technical Analysis

PURE Stock  USD 0.05  0.00  0.00%   
As of the 5th of February, Pure Bioscience holds the Variance of 62.51, coefficient of variation of (1,959), and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pure Bioscience, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Pure Bioscience, which can be compared to its competitors. Please check Pure Bioscience risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Pure Bioscience is priced some-what accurately, providing market reflects its current price of 0.05 per share. As Pure Bioscience appears to be a penny stock we also advise to check out its jensen alpha numbers.

Pure Bioscience Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Pure
  
Pure Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between Pure Bioscience's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pure Bioscience should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pure Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Pure Bioscience 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pure Bioscience's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pure Bioscience.
0.00
11/07/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/05/2026
0.00
If you would invest  0.00  in Pure Bioscience on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Pure Bioscience or generate 0.0% return on investment in Pure Bioscience over 90 days. Pure Bioscience is related to or competes with Exceed World, Indofood Agri, and CCA Industries. PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and enviro... More

Pure Bioscience Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pure Bioscience's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pure Bioscience upside and downside potential and time the market with a certain degree of confidence.

Pure Bioscience Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pure Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pure Bioscience's standard deviation. In reality, there are many statistical measures that can use Pure Bioscience historical prices to predict the future Pure Bioscience's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.057.68
Details
Intrinsic
Valuation
LowRealHigh
0.000.047.67
Details
Naive
Forecast
LowNextHigh
0.0010.057.67
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.040.050.05
Details

Pure Bioscience February 5, 2026 Technical Indicators

Pure Bioscience Backtested Returns

Pure Bioscience appears to be out of control, given 3 months investment horizon. Pure Bioscience maintains Sharpe Ratio (i.e., Efficiency) of 0.0368, which implies the firm had a 0.0368 % return per unit of risk over the last 3 months. We have found eighteen technical indicators for Pure Bioscience, which you can use to evaluate the volatility of the company. Please evaluate Pure Bioscience's Coefficient Of Variation of (1,959), risk adjusted performance of (0.03), and Variance of 62.51 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pure Bioscience holds a performance score of 2. The company holds a Beta of -0.41, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pure Bioscience are expected to decrease at a much lower rate. During the bear market, Pure Bioscience is likely to outperform the market. Please check Pure Bioscience's maximum drawdown and rate of daily change , to make a quick decision on whether Pure Bioscience's historical price patterns will revert.

Auto-correlation

    
  0.11  

Insignificant predictability

Pure Bioscience has insignificant predictability. Overlapping area represents the amount of predictability between Pure Bioscience time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pure Bioscience price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Pure Bioscience price fluctuation can be explain by its past prices.
Correlation Coefficient0.11
Spearman Rank Test0.53
Residual Average0.0
Price Variance0.0
Pure Bioscience technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Pure Bioscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pure Bioscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Pure Bioscience Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pure Bioscience volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Pure Bioscience Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pure Bioscience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pure Bioscience based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Pure Bioscience price pattern first instead of the macroeconomic environment surrounding Pure Bioscience. By analyzing Pure Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pure Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pure Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.

Pure Bioscience February 5, 2026 Technical Indicators

Most technical analysis of Pure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pure from various momentum indicators to cycle indicators. When you analyze Pure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Pure Bioscience February 5, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Pure stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Pure OTC Stock analysis

When running Pure Bioscience's price analysis, check to measure Pure Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Bioscience is operating at the current time. Most of Pure Bioscience's value examination focuses on studying past and present price action to predict the probability of Pure Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Bioscience's price. Additionally, you may evaluate how the addition of Pure Bioscience to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges